The EUGOGO 20th Anniversary Meeting
International Symposium on Graves\' Orbitopathy
The EUGOGO 20th Anniversary Meeting
International Symposium on Graves\' Orbitopathy
Endocrine Unit, Department of Medical Sciences University of Milan via Sforza 35,
A.I.C. Asti lncentives & Congressi
Piazza San Uomobono 30
56126 Pisa
Phone: +39 050 598808
Fax: +39 050 0987825
Organizer :
European Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences
University of Milan
Via Sforza 35
Secretary Dr. Mario Salvi
-
Basisinformation
Datum07.11.2019, 12:00 - 09.11.2019, 13:00SymposiumPisaSpracheEnglischGebühren ab450.00 EURVeranstalterEuropean Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences University of Milan via Sforza 35,OrganisatorA.I.C. Asti lncentives & Congressi
Piazza San Uomobono 30
56126 Pisa
Phone: +39 050 598808
Fax: +39 050 0987825Organizer :
European Group on Graves` Orbitopathy (EUGOGO)
Endocrine Unit, Department of Medical Sciences
University of Milan
Via Sforza 35
Secretary Dr. Mario Salvi -
VERANSTALTUNGSORT
Camera di Commercio di Pisa
Piazza Vittorio Emanuele II 5
56125 Pisa, IT -
Programm
SCIENTIFIC PROGRAM Thursday, November the 7th, 2019 12:00 - 13:00 Registration Opening Ceremony 13:00 - 13:15 Opening Ceremony 13:20 - 13:30 Tomb of Sarteano: the first GO painting in history Lelio Baldeschi (Brussels), Maurizio Martinelli (Firenze) 13:30 - 13:50 Mark Prummel memorial lecture Chairperson: Claudio Marcocci (Pisa) EUGOGO achievements over 20 years - Wilmar Wiersinga (Amsterdam) 13:55 - 15:35 Symposium 1: the lmmunopathogenesis of GO in 2019 Chairpersons: Paul Banga (London), Marvin Gershengorn (Bethesda) 13:55 - 14:15 Genetics and epigenetics of GO - Simon Pearce (Newcastle upon Tyne) 14:15 - 14:35 Role of fibrocytes in GO - Terry Smith (Ann Arbor) 14:35 - 14:55 Overview of the immune response in GO - Wilfern A. Dik (Amsterdam) 14:55 - 15:15 The microbioma in Graves' disease and GO - Marian Ludgate (Cardiff) 15:15 - 15:35 Graves' disease and GO following immune reconstitution Ilaria Muller (Cardiff) 15:40 - 16:40 Oral Presentations 1 Chairpersons: Nicola Curro (Milan), Michele Marino (Pisa) 16:40 - 17:00 Coffee Break 17:00 - 18:40 Symposium 2: diagnostic issues on GO phenotypes Chairpersons: Chistoph Hintschich (Munich), Ray Douglas (Los Angeles) 17:00 - 17:20 Unilateral, hypothyroid and euthyroid GO - Anja Eckstein (Essen) 17:20 - 17:40 Orbital volumetry and its significance - Wilmar Wiersinga (Amsterdam) 17:40 - 18:00 IgG4-related disease, the inflammatory neophyte in the orbit /lse Mombaerts (Leuven) 18:00 - 18:20 Differential diagnosis of GO: the importance of multidisciplinarity and specialized centers - Lelio Baldeschi (Brussels) 18:20 - 18:40 Diagnostic criteria and management of optic neuropathy - Antonella Boschi (Brussels) 18:45 - 19:05 George von Arx memorial lecture Chairperson: Lelio Baldeschi (Brussels) The importance of the ophthalmologist and of the joint clinic in GO / Nicole Fichter (Olfen) 19:05 - 20:00 Welcome Cocktail SCIENTIFIC PROGRAM Friday, November the 8th, 2019 8:30 - 8:50 Aldo Pinchera memorial lecture Chairperson: Paolo Vitti (Pisa) Epidemiology and secular trends of GO - Petros Perros (Newcastle upon Tyne) 8:55 - 9:15 Symposium 3: anlmal models of GD and GO Chairpersons: Marian Ludgate (Cardiff), Gerd Krause (Berlin) 8:55 - 9:15 Epitope peptides derived from the TSH receptor as an effective treatment in a mouse model of Graves' disease and GO - Martin Ungerer (Bavaria) The "English" model - Paul Banga (London) 9:35 - 9:55 The "German" model - Utta Berchner-Pfannshmidt (Essen) 10:00 - 11:00 Oral Presentations 2 Chairpersons: Katharina Ponto (Mainz), Milos iarkovic (Beigrade) 11:00 - 11:20 Coffee Break 11:20 - 12:40 Symposium 4: ophthalmologlcal controversles and unmet needs Chairpersons: Kostas Boboridis (Thessanoliki), Co/in Dayan (Cardiff) 11:20 - 11:40 EUGOGO consensus on eye motility assessment - Nicola Curro (Milan) 11:40 - 12:00 Assessment of primary and secondary outcomes of immunosuppressive treatment of active GO - Luigi Bartalena (Varese) 12:00 - 12:40 DEBATE: ls CAS always a reliable tool to define GO activity? Pro: Lucy Clark (Newcastle upon Tyne) Cons: Peter Dolman (Vancouver) 12:40 - 14:15 Lunch and Poster viewing 14:15 - 15:35 Symposium 5: from pathogenesis to medical treatment: focus on the TSH receptor Chairpersons: George Kahaly (Mainz), Terry Smith (Ann Arbour) 14:15 - 14:35 TSH receptor and signaling pathways - Gerd Krause (Berlin) 14:35 - 14:55 TSH receptor and lgF-1 receptor interactions - Marvin Gershengorn (Bethesda) 14:55 - 15.15 Small molecules antagonists as potential new agents for therapeutic targeting of the TSH receptor - Susanne Neumann (Bethesda) 15:15 - 15:35 TSH receptor monoclonal blocking antibodies - Wisia Furmaniak (Cardiff) 15:40 - 16:40 Symposium 6 (Part 1 ): old and novel treatment modalltles Chairpersons: Mario Sa/vi (Milan), Nichole Fichter (O/ten) 15:40 - 16:00 lntravenous glucocorticoids - C/audio Marcocci (Pisa) 16:00 - 16:20 Selenium - Michele Marino (Pisa) 16:20 - 16:40 Mycophenolate (The MINGO Study) - George Kahaly (Mainz) 16:40 - 17:00 Coffee Break 17:00 - 18:35 Symposium 6 (Part 2): Old and novel treatment modallties Chairpersons: Simon Pearce (Newcastle upon Tyne), Anja Eckstein (Essen) 17:00 - 17:20 Combined immunosuppression and radiotherapy (The CIRTED study) Peter N. Taylor (Cardiff) 17:20 - 17:40 Teprotumumab - Ray Douglas (Los Angeles) 17:40 - 18:00 Rituximab and other B cell targeting options - Mario Salvi (Milano) 18:00 - 18:20 Tocilizumab - Jose V. Perez-Moreiras (Santiago de Compostela) 18:20 - 18:50 lnteractive Discussion on Symposium 6 Chairmen: Luigi Bartalena (Varese) 18:20 - 18:25 Chairperson's summary 18:25 - 18:50 lnteractive discussion 20:30 - 23:30 Network Dinner SCIENTIFIC PROGRAM Saturday, November the 9th, 2019 8:30 - 9:50 Symposium 7: ophthalmic perspectives Chairpersons: Marco Nardi (Pisa), Peter Dolman (Vancouver) 8:30 - 8:50 Orbital decompression: does the approach matter? A review of the literature - Christoph Hintschich (Munich) 8:50 - 9:10 Outcome measures for strabismus surgery - Branislav Stancovic (Be/grade) 9:10 - 9:30 Treatment of eyelids and tear film alteration in GO - Kostas Boboridis (Thessaloniki) 9:30 - 9:50 Nanotechnology applied to Graves' Orbitopathy: a potential alternative to more invasive medical and surgical treatments - Djon Paridaens (Rotterdam) 9:55 - 10:55 Oral Presentations 3 Chairpersons: Goksun Ayvaz (Ankara), Antonella Boschi (Brussels) Coffee Break 10:55 . 11:15 Coffee Break 11:15 - 12:05 Patient Forum Chairpersons: Dan Morris (Cardiff), Petros Perros (Newcastle upon Tyne) 11:15 - 12:05 The quality of life in GO and the impact of GO in public health - Katharina Ponto (Mainz) 11:35 - 11:55 My life with GO - Janis Hickey (British Thyroid Foundation) 11:55 - 12:15 lmplementing change for improving the care of patients with GO: the TEAMED paradigm - Co/in Dayan (Cardiff) 12:15 - 12:35 Lecture Chairperson: Wilmar Wiersinga (Amsterdam) Quo vadis GO? - Marius Stan (USA) 12:40 - 1:00 Closing Ceremony DeadlinesAbstract
10.08.2019Hinweis
Abstract submission for oral and poster presentations are welcome - At least one author per abstract must be registered prior to abstract submission. In all other cases abstracts will be rejected -Acceptance or rejection will be confirmed by August 30th -Abstract should be no longer than 300 words, and should include Title, First and Last name of the authors separated by commas, affiliation/s of the authors -No images or pictures are allowed -Abstracts should be organized into the following sections: Background, Methods, Results, Conclusions. -
Gebühren
Fachärzte/-innenGebühren ab450,00 EURPrice for EUGOGO members : € 350,00
ACCOMPANYING PERSONS
(includes Welcome Reception at the Congress Venue and Congress Dinner) - € 160,00 -
Buchung / Anmeldung
Please contact A.I.C. Asti lncentives & Congressi for futher information.
-
Zertifizierung
Keine Zertifizierung beantragt
-
Sponsoren
EYEFOX.com sind bislang keine Sponsoren oder Aussteller bekannt. Wenn Sie die Veranstaltung als Sponsor oder Aussteller unterstützen, ergänzen wir das gerne kostenfrei.